The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

Clinical trial NCT06109558 · RECRUITING

Trial details

NCT number: NCT06109558
Sponsor: Hunan Province Tumor Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer RET Gene Mutation MET Amplification EGF-R Positive Non-Small Cell Lung Cancer

Start date: 2023-12-31
Primary completion: 2026-12-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.